These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25894140)

  • 41. Cutaneous disorders in liver transplant recipients.
    Tepeoğlu M; Özdemir BH; Taşlıca Z; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():101-5. PubMed ID: 24635804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.
    Farges O; Saliba F; Farhamant H; Samuel D; Bismuth A; Reynes M; Bismuth H
    Hepatology; 1996 Feb; 23(2):240-8. PubMed ID: 8591847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined heart and liver transplantation can be safely performed with excellent short- and long-term results.
    Atluri P; Gaffey A; Howard J; Phillips E; Goldstone AB; Hornsby N; MacArthur JW; Cohen JE; Gutsche J; Woo YJ
    Ann Thorac Surg; 2014 Sep; 98(3):858-62. PubMed ID: 25069688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit?
    Singhal A; Sezginsoy B; Ghuloom AE; Hutchinson IV; Cho YW; Jabbour N
    Exp Clin Transplant; 2010 Sep; 8(3):196-201. PubMed ID: 20716036
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Orthotopic liver transplantation without venovenous bypass: 125 cases from a single center.
    Miranda LE; de Melo PS; Sabat BD; Tenório AL; Lima DL; Neto OC; Amorim AG; Fernandez JL; de Macedo FI; Lacerda CM
    Transplant Proc; 2012 Oct; 44(8):2416-22. PubMed ID: 23026610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Post-transplant lymphoproliferative disorder in adult liver transplant recipients: a South American multicenter experience.
    Mendizabal M; Marciano S; dos Santos Schraiber L; Zapata R; Quiros R; Zanotelli ML; Rivas MM; Kusminsky G; Humeres R; Alves de Mattos A; Gadano A; Silva MO
    Clin Transplant; 2013; 27(4):E469-77. PubMed ID: 23758407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined lung and liver transplantation: analysis of a single-center experience.
    Yi SG; Burroughs SG; Loebe M; Scheinin S; Seethamraju H; Jyothula S; Monsour H; McFadden R; Podder H; Saharia A; Asham EH; Boktour M; Gaber AO; Ghobrial RM
    Liver Transpl; 2014 Jan; 20(1):46-53. PubMed ID: 24136814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome.
    Burroughs AK; Sabin CA; Rolles K; Delvart V; Karam V; Buckels J; O'Grady JG; Castaing D; Klempnauer J; Jamieson N; Neuhaus P; Lerut J; de Ville de Goyet J; Pollard S; Salizzoni M; Rogiers X; Muhlbacher F; Garcia Valdecasas JC; Broelsch C; Jaeck D; Berenguer J; Gonzalez EM; Adam R;
    Lancet; 2006 Jan; 367(9506):225-32. PubMed ID: 16427491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver transplantation for primary biliary cirrhosis in a hepatitis endemic region: a single-center Asian experience.
    Sun CK; Chen CL; Concejero AM; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC
    Clin Transplant; 2011; 25(1):47-53. PubMed ID: 20560991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of cytomegalovirus infection and disease with recurrent hepatitis C after liver transplantation.
    Bosch W; Heckman MG; Pungpapong S; Diehl NN; Shalev JA; Hellinger WC
    Transplantation; 2012 Apr; 93(7):723-8. PubMed ID: 22406819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.
    Angelico M; Cillo U; Fagiuoli S; Gasbarrini A; Gavrila C; Marianelli T; Costa AN; Nardi A; Strazzabosco M; Burra P; Agnes S; Baccarani U; Calise F; Colledan M; Cuomo O; De Carlis L; Donataccio M; Ettorre GM; Gerunda GE; Gridelli B; Lupo L; Mazzaferro V; Pinna A; Risaliti A; Salizzoni M; Tisone G; Valente U; Rossi G; Rossi M; Zamboni F;
    Dig Liver Dis; 2011 Feb; 43(2):155-64. PubMed ID: 21185796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
    Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simultaneous liver and kidney transplantation from different living donors.
    Soh KS; Jeng LB; Yang HR; Li PC; Lee CC; Poon KS; Chen TH; Yeh CC; Lai HC; Su WP; Peng CY; Chen YF; Ho YJ
    Transplant Proc; 2012 Mar; 44(2):509-11. PubMed ID: 22410057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Right-liver living donor transplantation for decompensated end-stage liver disease.
    Testa G; Malagó M; Nadalin S; Hertl M; Lang H; Frilling A; Broelsch CE
    Liver Transpl; 2002 Apr; 8(4):340-6. PubMed ID: 11965577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Late acute liver allograft rejection; a study of its natural history and graft survival in the current era.
    Thurairajah PH; Carbone M; Bridgestock H; Thomas P; Hebbar S; Gunson BK; Shah T; Neuberger J
    Transplantation; 2013 Apr; 95(7):955-9. PubMed ID: 23442806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The outcome of heart transplantation in hepatitis C-positive recipients.
    Lin MH; Chou NK; Chi NH; Chen YS; Yu HY; Huang SC; Ko WJ; Chou HW; Wang SS
    Transplant Proc; 2012 May; 44(4):890-3. PubMed ID: 22564576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.
    Citores MJ; Baños I; Noblejas A; Rosado S; Castejon R; Cuervas-Mons V
    Transplant Proc; 2011; 43(6):2224-6. PubMed ID: 21839239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.